Senhwa Biosciences, Inc. (TPEX:6492)

Senhwa Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	894.14	1,026	1,319	1,619	2,033	2,369
Cash & Short-Term Investments	894.14	1,026	1,319	1,619	2,033	2,369
Cash Growth	-23.38%	-22.20%	-18.55%	-20.34%	-14.19%	182.89%
Accounts Receivable	-	-	-	-	0.19	-
Other Receivables	0.13	0.18	10.59	8.64	7	6.4
Receivables	0.13	0.18	10.59	8.64	7.18	6.4
Prepaid Expenses	6.39	8.69	6.74	5.51	1.62	3.38
Other Current Assets	-	-	-	4.18	3.35	4.91
Total Current Assets	900.66	1,035	1,336	1,637	2,045	2,383
Property, Plant & Equipment	28.08	17.2	14.37	15.75	15.42	9.9
Long-Term Investments	0	0	0.13	0.13	0.13	0.13
Other Intangible Assets	0.09	0.14	0.23	-	0.07	-
Other Long-Term Assets	14.88	13.78	12.46	1.54	1.32	1.88
Total Assets	943.71	1,066	1,363	1,655	2,062	2,395
Accrued Expenses	-	21.58	32.37	22.04	75.63	47.59
Current Portion of Long-Term Debt	-	-	-	-	-	7.2
Current Portion of Leases	9.04	7.16	6.31	8.18	5.17	4.18
Current Income Taxes Payable	-	0.14	-	-	-	-
Other Current Liabilities	14.42	2.21	4.2	2.73	1.43	2.3
Total Current Liabilities	23.47	31.09	42.89	32.95	82.23	61.27
Long-Term Debt	-	-	-	-	-	2.06
Long-Term Leases	17.18	7.84	3.29	7.98	10.21	5.67
Total Liabilities	40.64	38.93	46.18	40.93	92.44	68.99
Common Stock	897.04	897.44	897.44	897.44	897.44	896.58
Additional Paid-In Capital	175.5	469.58	765.88	1,116	1,444	1,790
Retained Earnings	-118.88	-293.87	-296.31	-349.63	-329.26	-354.88
Treasury Stock	-49.36	-51.35	-51.35	-51.35	-38.11	-1.99
Comprehensive Income & Other	-1.22	5.24	1.49	1.35	-5.24	-3.39
Shareholders' Equity	903.07	1,027	1,317	1,614	1,969	2,326
Total Liabilities & Equity	943.71	1,066	1,363	1,655	2,062	2,395
Total Debt	26.22	15	9.6	16.16	15.38	19.11
Net Cash (Debt)	867.92	1,011	1,309	1,603	2,017	2,349
Net Cash Growth	-24.36%	-22.78%	-18.33%	-20.54%	-14.14%	183.16%
Net Cash Per Share	9.74	11.34	14.68	17.97	22.50	29.75
Filing Date Shares Outstanding	89.1	89.19	89.19	88.63	89.31	89.62
Total Common Shares Outstanding	89.1	89.19	89.19	88.63	89.31	89.62
Working Capital	877.19	1,004	1,293	1,605	1,963	2,322
Book Value Per Share	10.14	11.52	14.77	18.21	22.05	25.96
Tangible Book Value	902.98	1,027	1,317	1,614	1,969	2,326
Tangible Book Value Per Share	10.13	11.51	14.77	18.21	22.05	25.96

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.